Antiviral Research 48 (2000) 211 – 213
Subject index
Volume 48 (2000)
Adefovir; CRPV; Papillomas; Rabbits; Cidofovir; Nucleoside analogues; Antiviral testing 48, 131
Antiherpetic activity; Santolina insularis; Essential oil; Viruci-dal agent; HSV-1; HSV-2 48, 177
Antisense; Papillomavirus; Oligonucleotides; Non-specific an-tiviral; HPV11; HPV40 48, 187
Antiviral activity; Human cytomegalovirus; Protein kinase; Indolocarbazole 48, 49
Antiviral agents; Human influenza A viruses; Avian influenza viruses 48, 101
Antiviral; Broad spectrum; Crustaceans; Innate immunity 48, 39
Antiviral defenses; Innate antivirals 48, 71
Antiviral drug; Poliovirus; 5-(3,4-dichlorophenyl) methylhy-dantoin; Cell-free system 48, 61
Antiviral testing; CRPV; Papillomas; Rabbits; Cidofovir; Nu-cleoside analogues; Adefovir 48, 131
Avian influenza viruses; Human influenza A viruses; Antiviral agents 48, 101
Broad spectrum; Antiviral; Crustaceans; Innate immunity 48, 39
Carbocyclic guanosine nucleoside analogues; Hepatitis B virus (HBV); Woodchuck hepatitis virus (WHV); Lobucavir; Wood-chucks (Marmota monax); Chronic virus infection 48, 197
cccDNA; DHBV; Liver; Competitive PCR; Hepadnavirus 48, 27
Cell cycle sensitivity; Hepatitis C; Interferon; Ribavirin; Im-munomodulation; Interferon receptor 48, 91
Cell-free system; Poliovirus; 5-(3,4-dichlorophenyl) methylhy-dantoin; Antiviral drug 48, 61
Cell models; HIV-1 latency; Therapeutic intervention; Viral transcription 48, 143
Chronic liver disease; Hepatitis B virus treatment; Oral toler-ance; Immune response 48, 17
Chronic virus infection; Hepatitis B virus (HBV); Woodchuck hepatitis virus (WHV); Lobucavir; Woodchucks (Marmota monax); Carbocyclic guanosine nucleoside analogues 48, 197
Cidofovir; CRPV; Papillomas; Rabbits; Nucleoside analogues; Adefovir; Antiviral testing 48, 131
Cidofovir; Parapoxvirus; Orf; Pseudocowpox; Milker’s nod-ule 48, 205
Coho salmon; EICAR; In vivo; Rainbow trout; IPNV ther-apy 48, 125
Competitive PCR; DHBV; cccDNA; Liver; Hepadnavirus 48, 27
CRPV; Papillomas; Rabbits; Cidofovir; Nucleoside analogues; Adefovir; Antiviral testing 48, 131
Crustaceans; Antiviral; Broad spectrum; Innate immunity 48, 39
DHBV; cccDNA; Liver; Competitive PCR; Hepad-navirus 48, 27
5-(3,4-dichlorophenyl) methylhydantoin; Poliovirus; Antiviral drug; Cell-free system 48, 61
EICAR; In vivo; Rainbow trout; Coho salmon; IPNV ther-apy 48, 125
Subject index
212
Essential oil;Santolina insularis; Antiherpetic activity; Viruci-dal agent; HSV-1; HSV-2 48, 177
HBV; Ribavirin; Mycophenolic acid; Transplantation 48, 117
Hepadnavirus; DHBV; cccDNA; Liver; Competitive PCR 48, 27
Hepatitis B virus (HBV); Woodchuck hepatitis virus (WHV); Lobucavir; Woodchucks (Marmota monax); Carbocyclic guanosine nucleoside analogues; Chronic virus infection 48, 197
Hepatitis B virus treatment; Oral tolerance; Immune response; Chronic liver disease 48, 17
Hepatitis C; Interferon; Ribavirin; Immunomodulation; Cell cycle sensitivity; Interferon receptor 48, 91
HIV-1 latency; Therapeutic intervention; Cell models; Viral transcription 48, 143
HPV40; Antisense; Papillomavirus; Oligonucleotides; Non-specific antiviral; HPV11 48, 187
HPV11; Antisense; Papillomavirus; Oligonucleotides; Non-specific antiviral; HPV40 48, 187
HSV-2;Santolina insularis; Essential oil; Antiherpetic activity; Virucidal agent; HSV-1 48, 177
HSV-1;Santolina insularis; Essential oil; Antiherpetic activity; Virucidal agent; HSV-2 48, 177
Human cytomegalovirus; Antiviral activity; Protein kinase; In-dolocarbazole 48, 49
Human influenza A viruses; Avian influenza viruses; Antiviral agents 48, 101
Immune response; Hepatitis B virus treatment; Oral tolerance; Chronic liver disease 48, 17
Immunomodulation; Hepatitis C; Interferon; Ribavirin; Cell cycle sensitivity; Interferon receptor 48, 91
Indolocarbazole; Human cytomegalovirus; Antiviral activity; Protein kinase 48, 49
Influenza; Zanamivir; Oseltamivir 48, 1
Innate antivirals; Antiviral defenses 48, 71
Innate immunity; Antiviral; Broad spectrum; Crustaceans 48, 39
Interferon; Hepatitis C; Ribavirin; Immunomodulation; Cell cycle sensitivity; Interferon receptor 48, 91
Interferon receptor; Hepatitis C; Interferon; Ribavirin; Im-munomodulation; Cell cycle sensitivity 48, 91
In vivo; EICAR; Rainbow trout; Coho salmon; IPNV ther-apy 48, 125
IPNV therapy; EICAR; In vivo; Rainbow trout; Coho salmon 48, 125
Liver; DHBV; cccDNA; Competitive PCR; Hepad-navirus 48, 27
Lobucavir; Hepatitis B virus (HBV); Woodchuck hepatitis virus (WHV); Woodchucks (Marmota monax); Carbocyclic guanosine nucleoside analogues; Chronic virus infection 48, 197
Milker’s nodule; Cidofovir; Parapoxvirus; Orf; Pseudocow-pox 48, 205
Mycophenolic acid; HBV; Ribavirin; Transplantation 48, 117
Non-specific antiviral; Antisense; Papillomavirus; Oligonucle-otides; HPV11; HPV40 48, 187
Nucleoside analogues; CRPV; Papillomas; Rabbits; Cidofovir; Adefovir; Antiviral testing 48, 131
Oligonucleotides; Antisense; Papillomavirus; Non-specific an-tiviral; HPV11; HPV40 48, 187
Oral tolerance; Hepatitis B virus treatment; Immune response; Chronic liver disease 48, 17
Orf; Cidofovir; Parapoxvirus; Pseudocowpox; Milker’s nod-ule 48, 205
Oseltamivir; Influenza; Zanamivir 48, 1
Papillomas; CRPV; Rabbits; Cidofovir; Nucleoside analogues; Adefovir; Antiviral testing 48, 131
Papillomavirus; Antisense; Oligonucleotides; Non-specific an-tiviral; HPV11; HPV40 48, 187
Parapoxvirus; Cidofovir; Orf; Pseudocowpox; Milker’s nod-ule 48, 205
Poliovirus; 5-(3,4-dichlorophenyl) methylhydantoin; Antiviral drug; Cell-free system 48, 61
Protein kinase; Human cytomegalovirus; Antiviral activity; Indolocarbazole 48, 49
Subject index 213
Rabbits; CRPV; Papillomas; Cidofovir; Nucleoside analogues; Adefovir; Antiviral testing 48, 131
Rainbow trout; EICAR; In vivo; Coho salmon; IPNV ther-apy 48, 125
Ribavirin; HBV; Mycophenolic acid; Transplantation 48, 117
Ribavirin; Hepatitis C; Interferon; Immunomodulation; Cell cycle sensitivity; Interferon receptor 48, 91
Santolina insularis; Essential oil; Antiherpetic activity; Viruci-dal agent; HSV-1; HSV-2 48, 177
Therapeutic intervention; HIV-1 latency; Cell models; Viral transcription 48, 143
Transplantation; HBV; Ribavirin; Mycophenolic acid 48, 117
Viral transcription; HIV-1 latency; Therapeutic intervention; Cell models 48, 143
Virucidal agent;Santolina insularis; Essential oil; Antiherpetic activity; HSV-1; HSV-2 48, 177
Woodchuck hepatitis virus (WHV); Hepatitis B virus (HBV); Lobucavir; Woodchucks (Marmota monax); Carbocyclic guanosine nucleoside analogues; Chronic virus infection 48, 197
Woodchucks (Marmota monax); Hepatitis B virus (HBV); Woodchuck hepatitis virus (WHV); Lobucavir; Carbocyclic guanosine nucleoside analogues; Chronic virus infection 48, 197
